Fidelity International’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.4M Sell
21,114
-72,294
-77% -$32.2M 0.01% 550
2025
Q1
$45.3M Buy
93,408
+135
+0.1% +$65.5K 0.04% 325
2024
Q4
$37.6M Buy
93,273
+86,242
+1,227% +$34.7M 0.04% 364
2024
Q3
$3.27M Sell
7,031
-674
-9% -$313K ﹤0.01% 661
2024
Q2
$3.61M Buy
7,705
+7,020
+1,025% +$3.29M ﹤0.01% 634
2024
Q1
$286K Buy
685
+3
+0.4% +$1.25K ﹤0.01% 786
2023
Q4
$277K Buy
+682
New +$277K ﹤0.01% 757
2023
Q3
Sell
-47,037
Closed -$16.6M 853
2023
Q2
$16.6M Sell
47,037
-901
-2% -$317K 0.02% 429
2023
Q1
$15.1M Sell
47,938
-167,736
-78% -$52.8M 0.02% 426
2022
Q4
$62.3M Sell
215,674
-34,019
-14% -$9.82M 0.07% 267
2022
Q3
$72.3M Buy
249,693
+2,140
+0.9% +$620K 0.09% 229
2022
Q2
$69.8M Buy
247,553
+105,668
+74% +$29.8M 0.08% 239
2022
Q1
$37M Buy
141,885
+137,222
+2,943% +$35.8M 0.04% 340
2021
Q4
$1.02M Buy
4,663
+3,952
+556% +$868K ﹤0.01% 734
2021
Q3
$129K Sell
711
-114,250
-99% -$20.7M ﹤0.01% 792
2021
Q2
$23.2M Sell
114,961
-48,928
-30% -$9.87M 0.02% 434
2021
Q1
$35.2M Buy
163,889
+163,804
+192,711% +$35.2M 0.04% 339
2020
Q4
$20K Sell
85
-88,400
-100% -$20.8M ﹤0.01% 791
2020
Q3
$24.1M Sell
88,485
-52,485
-37% -$14.3M 0.03% 368
2020
Q2
$40.9M Sell
140,970
-97,141
-41% -$28.2M 0.06% 280
2020
Q1
$56.7M Buy
238,111
+194,406
+445% +$46.3M 0.09% 213
2019
Q4
$9.57M Buy
43,705
+43,699
+728,317% +$9.57M 0.01% 509
2019
Q3
$1K Buy
6
+1
+20% +$167 ﹤0.01% 868
2019
Q2
$1K Sell
5
-1
-17% -$200 ﹤0.01% 873
2019
Q1
$1K Buy
6
+1
+20% +$167 ﹤0.01% 844
2018
Q4
$1K Hold
5
﹤0.01% 832
2018
Q3
$1K Buy
+5
New +$1K ﹤0.01% 895
2017
Q3
Sell
-163,316
Closed -$21M 523
2017
Q2
$21M Sell
163,316
-137,392
-46% -$17.7M 0.06% 233
2017
Q1
$32.9M Buy
300,708
+183,655
+157% +$20.1M 0.09% 192
2016
Q4
$8.62M Buy
+117,053
New +$8.62M 0.03% 346
2014
Q1
Sell
-56,921
Closed -$4.23M 645
2013
Q4
$4.23M Sell
56,921
-241,979
-81% -$18M 0.02% 401
2013
Q3
$22.7M Sell
298,900
-6,000
-2% -$455K 0.11% 192
2013
Q2
$24.4M Buy
+304,900
New +$24.4M 0.14% 174